Osteoblast-specific GPR41/43 null mice will be utilized to probe the involvement of these receptors in the signaling axis leading from gut microbiome alterations to bone changes in SCD in future studies. The gene discussed is FFAR3; the disease is Schnyder corneal dystrophy.